COMPANY TYPE DESCRIPTION PHASE DESCRIPTION
3P BIOPHARMACEUTICALS CRO / CMO Strain development and RCB manufacturing in microbial expression systems (Bacteria and yeast) 5RTM Strain development and RCB manufacturing in microbial expression systems (Bacteria and yeast)
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Stability studies services 5RTM Stability studies services
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Mammalian cell line development 5RTM Mammalian cell line development
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO GMP Cell Bank Manufacturing (MCB, WCB) and storage 5RTM GMP Cell Bank Manufacturing (MCB, WCB) and storage
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Analytical methods development, qualification and validation platform for NBE and Biosimilars 5RTM Analytical methods development, qualification and validation platform for NBE and Biosimilars
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Process development, optimization and formulation development 5RTM Process development, optimization and formulation development
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Technology transfer, Scale-up and non-GMP manufacturing services 5RTM Technology transfer, Scale-up and non-GMP manufacturing services
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO GMP manufacturing mammalian services (up to 2000L) 5RTM GMP manufacturing mammalian services (up to 2000L)
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO GMP manufacturing microbial services (up to 1000L) 5RTM GMP manufacturing microbial services (up to 1000L)
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Cell therapy services 5RTM Cell therapy services
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO GMP manufacturing services for Clinical Trials and Commercial 5RTM GMP manufacturing services for Clinical Trials and Commercial
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO DS & DP Testing and release 5RTM DS & DP Testing and release
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Comparability studies services 5RTM Comparability studies services
Type: CRO / CMO
ADL Bionatur Solutions CRO / CMO
Screening
Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies. 5RTM Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies.
Type: CRO / CMO
Screening
ADL Bionatur Solutions Drug Delivery
Enabling Technologies
VACC-ZERA platform for improvement of the immune response raised by recombinant vaccines (proteins or DNA/RNA vaccines). Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery. 3CV VACC-ZERA platform for improvement of the immune response raised by recombinant vaccines (proteins or DNA/RNA vaccines). Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery.
Type: Drug Delivery
Enabling Technologies
ADL Bionatur Solutions CRO / CMO
Enabling Technologies
CLICK-GENE. SPLITTERA platform for gene therapy and gene editing. Overcomes gene size limitations of viral vectors by in-vivo covalent reconstitution of large proteins mediated by split inteins. 2PreV CLICK-GENE. SPLITTERA platform for gene therapy and gene editing. Overcomes gene size limitations of viral vectors by in-vivo covalent reconstitution of large proteins mediated by split inteins.
Type: CRO / CMO
Enabling Technologies
ADL Bionatur Solutions CRO / CMO
Enabling Technologies
Screening
CLICK-BIO. SPLITTERA Split-intein site-specific protein conjugation platform. Allows functionalization of any Ab format or protein. Capacity to obtain tailor-made antibodies libraries with unique features. 5RTM CLICK-BIO. SPLITTERA Split-intein site-specific protein conjugation platform. Allows functionalization of any Ab format or protein. Capacity to obtain tailor-made antibodies libraries with unique features.
Type: CRO / CMO
Enabling Technologies
Screening
ADL Bionatur Solutions Drug Delivery
Enabling Technologies
CLICK-VLP. Split Intein-mediated ANTIGEN DISPLAY for VLPs surface functionalization. It’s a “glue“ for functioning VLPs, overcoming limitations in production of classical VLPs. 3CV CLICK-VLP. Split Intein-mediated ANTIGEN DISPLAY for VLPs surface functionalization. It’s a “glue“ for functioning VLPs, overcoming limitations in production of classical VLPs.
Type: Drug Delivery
Enabling Technologies
ADL Bionatur Solutions CRO / CMO
Drug Delivery
Enabling Technologies
CLICK-TARGET. SPLITTERA technology for gene therapy. Allows the decoration of viral particles with covalently bound effectors making possible to target viral particles to specific tissues. 2PreV CLICK-TARGET. SPLITTERA technology for gene therapy. Allows the decoration of viral particles with covalently bound effectors making possible to target viral particles to specific tissues.
Type: CRO / CMO
Drug Delivery
Enabling Technologies
ADM BIOPOLIS CRO / CMO Contract manufacturing: upstream and downstream development, analytical development, scale-up 5RTM Contract manufacturing: upstream and downstream development, analytical development, scale-up
Type: CRO / CMO
ADM BIOPOLIS CRO / CMO Metagenomics and metabolomic analysis 5RTM Metagenomics and metabolomic analysis
Type: CRO / CMO
ADM BIOPOLIS CRO / CMO
Screening
Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials 5RTM Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials
Type: CRO / CMO
Screening
ADM BIOPOLIS CRO / CMO
Screening
Novel functional probiotics screening, validation and production 1R+D Novel functional probiotics screening, validation and production
Type: CRO / CMO
Screening
ADM BIOPOLIS CRO / CMO Recombinant protein expression systems 1R+D Recombinant protein expression systems
Type: CRO / CMO
APTUS Biotech Drug Delivery
Enabling Technologies
Screening
AptusBiotech has built an aptamer development platform, from cell lines to protein, peptides or small molecule selections procedures, providing high quality candidates for pre-clinical trials with an innovative drug development process based on aptamers 1R+D AptusBiotech has built an aptamer development platform, from cell lines to protein, peptides or small molecule selections procedures, providing high quality candidates for pre-clinical trials with an innovative drug development process based on aptamers
Type: Drug Delivery
Enabling Technologies
Screening
Arthex Biotech Drug Delivery ENTRY Platform: Enhancing antimiR delivery to treat unmet diseases. ARTHEx biotech launches ENTRY,a platform that will allow it to advance its pipeline of drugs by providing tissue-enriched delivery of antimiRs. The ENTRY platform improves drug delivery 2PreV ENTRY Platform: Enhancing antimiR delivery to treat unmet diseases. ARTHEx biotech launches ENTRY,a platform that will allow it to advance its pipeline of drugs by providing tissue-enriched delivery of antimiRs. The ENTRY platform improves drug delivery
Type: Drug Delivery
Biobide CRO / CMO
Screening
Zebrafish Toxicity screening assays for Pharma, Biotech, Chemical, Agrochemical, Tobacco, Nutraceutical, and Cosmetic companies for candidate selection in early discovery and development phases:Developmental toxicity, Neurotoxicity, Cardiotoxicity, Hepati 5RTM Zebrafish Toxicity screening assays for Pharma, Biotech, Chemical, Agrochemical, Tobacco, Nutraceutical, and Cosmetic companies for candidate selection in early discovery and development phases:Developmental toxicity, Neurotoxicity, Cardiotoxicity, Hepati
Type: CRO / CMO
Screening
Biobide CRO / CMO Zebrafish Lines Management:In parallel to the increase in the use of zebrafish as an animal model, Biobide has developed a Zebrafish Sperm Cryopreservation and In vitro fertilization protocol to answer the need to implement a program to reduce the number 5RTM Zebrafish Lines Management:In parallel to the increase in the use of zebrafish as an animal model, Biobide has developed a Zebrafish Sperm Cryopreservation and In vitro fertilization protocol to answer the need to implement a program to reduce the number
Type: CRO / CMO
Biobide CRO / CMO
Screening
Zebrafish Efficacy Assays for different therapeutic areas in drug discovery: Neurodegenerative diseases, Oncology, Cardiovascular, Immune diseases, Infectious diseases, Rare diseases (DMD, ALS...), other models, etc. 5RTM Zebrafish Efficacy Assays for different therapeutic areas in drug discovery: Neurodegenerative diseases, Oncology, Cardiovascular, Immune diseases, Infectious diseases, Rare diseases (DMD, ALS...), other models, etc.
Type: CRO / CMO
Screening
Biobide CRO / CMO
Screening
Zebrafish Disease Model Generation and Target Identification and Validation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemically induced models, xenograft models, etc. 5RTM Zebrafish Disease Model Generation and Target Identification and Validation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemically induced models, xenograft models, etc.
Type: CRO / CMO
Screening
BIONET INGENIERÍA Enabling Technologies Smart functional modules to be coupled to bioreactor technologies in a Plug&Play fashion. Examples of these are the Continuous Process Modules for performance of continuous processing, and the bBreath module for the analysis of gas composition at the exha 5RTM Smart functional modules to be coupled to bioreactor technologies in a Plug&Play fashion. Examples of these are the Continuous Process Modules for performance of continuous processing, and the bBreath module for the analysis of gas composition at the exha
Type: Enabling Technologies
BIONET INGENIERÍA CRO / CMO
Enabling Technologies
Screening
Rocking bioreactor with patentend 2D movement (Cell-tainer Biosolutions GmbH) for microbial and cell culture applications. Lab and Pilot scale. 5RTM Rocking bioreactor with patentend 2D movement (Cell-tainer Biosolutions GmbH) for microbial and cell culture applications. Lab and Pilot scale.
Type: CRO / CMO
Enabling Technologies
Screening
BIONET INGENIERÍA CRO / CMO
Enabling Technologies
Screening
Glass labscale bioreactors 5RTM Glass labscale bioreactors
Type: CRO / CMO
Enabling Technologies
Screening
BIONET INGENIERÍA Enabling Technologies
Screening
Labscale Tangential Flow Filtration units, very flexible for R&D since it allows the integration of all types of membranes: ceramic, hollow fiber and cassettes 5RTM Labscale Tangential Flow Filtration units, very flexible for R&D since it allows the integration of all types of membranes: ceramic, hollow fiber and cassettes
Type: Enabling Technologies
Screening
CIBER Enabling Technologies
Others
High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine 1R+D High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type: Enabling Technologies
Others
CIBER Others NewroPharma: A Target Validation Platform, provide a comprehensive list of preclinical drug development services to pharmaceutical partners. 2PreV NewroPharma: A Target Validation Platform, provide a comprehensive list of preclinical drug development services to pharmaceutical partners.
Type: Others
CIBER CRO / CMO
Enabling Technologies
Screening
Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine 2PreV Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type: CRO / CMO
Enabling Technologies
Screening
CIBER Others Bilateral Pupillometry Platform for small Animals 2PreV Bilateral Pupillometry Platform for small Animals
Type: Others
CIBER CRO / CMO
Enabling Technologies
Preclinical Validation-Tissue, Biomaterial and Surface Characterization 2PreV Preclinical Validation-Tissue, Biomaterial and Surface Characterization
Type: CRO / CMO
Enabling Technologies
CIBER CRO / CMO
Enabling Technologies
Others
Production of Customized Biomaterials, Nanomaterials & Nanoconjugates 5RTM Production of Customized Biomaterials, Nanomaterials & Nanoconjugates
Type: CRO / CMO
Enabling Technologies
Others
CIBER CRO / CMO
Enabling Technologies
Others
Production of Customized Biomolecules (Antibodies, Proteins and Peptides) 5RTM Production of Customized Biomolecules (Antibodies, Proteins and Peptides)
Type: CRO / CMO
Enabling Technologies
Others
Enzymlogic CRO / CMO
Screening
KINETICfinder® is a high throughput kinetic platform that delivers all key binding kinetics (kon, koff, residence time) and affinity (Kd) parameters for reversible binders quickly and at scale. 5RTM KINETICfinder® is a high throughput kinetic platform that delivers all key binding kinetics (kon, koff, residence time) and affinity (Kd) parameters for reversible binders quickly and at scale.
Type: CRO / CMO
Screening
Enzymlogic CRO / CMO
Screening
COVALfinder® is a robust kinetic platform that delivers all key inactivation (kinact, kinact/KI, T1/2∞) and affinity (KI) parameters for irreversible binders. 5RTM COVALfinder® is a robust kinetic platform that delivers all key inactivation (kinact, kinact/KI, T1/2∞) and affinity (KI) parameters for irreversible binders.
Type: CRO / CMO
Screening
FUND. PROGRESO Y SALUD Enabling Technologies Hybridome/Antibody Production Platform 1R+D Hybridome/Antibody Production Platform
Type: Enabling Technologies
FUND. PROGRESO Y SALUD CRO / CMO Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials 3CV Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials
Type: CRO / CMO
FUND. PROGRESO Y SALUD Drug Delivery Liposome delivery System (Prostate Cancer) 1R+D Liposome delivery System (Prostate Cancer)
Type: Drug Delivery
FUND. PROGRESO Y SALUD Screening Screening Cell lines & Animal Models 1R+D Screening Cell lines & Animal Models
Type: Screening
FUND. PROGRESO Y SALUD CRO / CMO Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank 5RTM Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank
Type: CRO / CMO
Fundacion MEDINA CRO / CMO Chemical Isolation & Structural Elucidation of natural products 3CV Chemical Isolation & Structural Elucidation of natural products
Type: CRO / CMO
Fundacion MEDINA Enabling Technologies
Screening
Mass spectrometry metabolomics 1R+D Mass spectrometry metabolomics
Type: Enabling Technologies
Screening
Fundacion MEDINA CRO / CMO Microbial and Mammalian cell culturing 3CV Microbial and Mammalian cell culturing
Type: CRO / CMO
Fundacion MEDINA Screening High throughput imaging platform for phenotypic drug discovery 2PreV High throughput imaging platform for phenotypic drug discovery
Type: Screening
Fundacion MEDINA Screening Microbial Natural Product Libraries 3CV Microbial Natural Product Libraries
Type: Screening
Fundacion MEDINA CRO / CMO Preclinical Safety Platform 3CV Preclinical Safety Platform
Type: CRO / CMO
Fundacion MEDINA CRO / CMO Bioanalytical Platform 3CV Bioanalytical Platform
Type: CRO / CMO
Fundacion MEDINA Screening High throughput screening platform for drug discovery 3CV High throughput screening platform for drug discovery
Type: Screening
Histocell CRO / CMO GMP Cell Bank Therapy Manufacturing (MCB, WCB) 5RTM GMP Cell Bank Therapy Manufacturing (MCB, WCB)
Type: CRO / CMO
Histocell CRO / CMO GMP Cell Therapy Manufacturing (DS & DP) 5RTM GMP Cell Therapy Manufacturing (DS & DP)
Type: CRO / CMO
Histocell CRO / CMO GMP Biological Product Manufacturing from Human Cells (DS & DP) 5RTM GMP Biological Product Manufacturing from Human Cells (DS & DP)
Type: CRO / CMO
IIS La Fe Enabling Technologies
Screening
Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening 1R+D Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening
Type: Enabling Technologies
Screening
IIS La Fe Screening Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques 3CV Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques
Type: Screening
IIS La Fe CRO / CMO
Drug Delivery
Advanced Therapies Unit: offers services that require specially designed infrastructures under the most demanding regulatory framework for the development of pre-clinical and clinical studies within the Advanced Therapies programs. 5RTM Advanced Therapies Unit: offers services that require specially designed infrastructures under the most demanding regulatory framework for the development of pre-clinical and clinical studies within the Advanced Therapies programs.
Type: CRO / CMO
Drug Delivery
IIS La Fe Enabling Technologies Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.) 1R+D Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.)
Type: Enabling Technologies
IIS La Fe Screening Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour). 2PreV Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour).
Type: Screening
IIS La Fe Enabling Technologies Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions 2PreV Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions
Type: Enabling Technologies
IIS La Fe CRO / CMO Clinical and Products with Biological Activity Research Unit (UICAB): Participates in the development of clinical studies aimed at different pathologies, providing healthcare support in highly complex studies, such as Clinical Trials in early phases 5RTM Clinical and Products with Biological Activity Research Unit (UICAB): Participates in the development of clinical studies aimed at different pathologies, providing healthcare support in highly complex studies, such as Clinical Trials in early phases
Type: CRO / CMO
IIS La Fe Enabling Technologies Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc. 1R+D Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc.
Type: Enabling Technologies
IIS La Fe Screening Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE) 1R+D Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE)
Type: Screening
IIS La Fe Biolectronics, Signal Processing and Algorithmy Unit: provides support in the development of medical devices related to advanced signal processing, for the optimization of diagnostics and therapeutic applications. 1R+D Biolectronics, Signal Processing and Algorithmy Unit: provides support in the development of medical devices related to advanced signal processing, for the optimization of diagnostics and therapeutic applications.
Type:
IIS La Fe Screening Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform 1R+D Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform
Type: Screening
IMMUNOSTEP Enabling Technologies Reagents, columns and devices for Cell separation in Blood and Lymphatic systems 2PreV Reagents, columns and devices for Cell separation in Blood and Lymphatic systems
Type: Enabling Technologies
IMMUNOSTEP Enabling Technologies This kit is intended for RUO in the purification and identification of human exosomes from Cell Culture, Blood and Urine samples, For flow cytometric detection. 5RTM This kit is intended for RUO in the purification and identification of human exosomes from Cell Culture, Blood and Urine samples, For flow cytometric detection.
Type: Enabling Technologies
Institut Quimic de Sarrià (IQS) CRO / CMO
Drug Delivery
Enabling Technologies
Peptides. Design, optimization and production of peptides and conjugates. 1R+D Peptides. Design, optimization and production of peptides and conjugates.
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Institut Quimic de Sarrià (IQS) CRO / CMO
Drug Delivery
Enabling Technologies
Others
Biomaterials and Nanomaterials. Development of nanomaterials and nanoparticles. Biopolymers and lipidic vesicles. 5RTM Biomaterials and Nanomaterials. Development of nanomaterials and nanoparticles. Biopolymers and lipidic vesicles.
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Others
Institut Quimic de Sarrià (IQS) CRO / CMO Animal cell bioprocess. Production of biomolecules. Process development & optimization. Bioreactors. 5RTM Animal cell bioprocess. Production of biomolecules. Process development & optimization. Bioreactors.
Type: CRO / CMO
Institut Quimic de Sarrià (IQS) CRO / CMO
Screening
Analytics. GMP Analytical services: Development and routine analysis of bioproducts. 1R+D Analytics. GMP Analytical services: Development and routine analysis of bioproducts.
Type: CRO / CMO
Screening
IRYCIS Others
Screening
miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response 3CV miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response
Type: Others
Screening
Laminar Pharma Enabling Technologies Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism 3CV Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism
Type: Enabling Technologies
Leitat CRO / CMO
Enabling Technologies
Screening
In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models) Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient 5RTM In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models) Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient
Type: CRO / CMO
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling). Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells. 5RTM In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling). Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells.
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Polyclonal & Monoclonal Antibody Generation and Production Platform. Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab)2, scFv, Conjugation, ELISA 5RTM Polyclonal & Monoclonal Antibody Generation and Production Platform. Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab)2, scFv, Conjugation, ELISA
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Microomics Systems CRO / CMO
Enabling Technologies
Screening
High quality metagenomics, genomics and transcriptomics services to companies industrial research centers in the fields of: pre and probiotics, metabolic studies, human and animal health, dental treatments and agriculture solutions (biofertilizers) 5RTM High quality metagenomics, genomics and transcriptomics services to companies industrial research centers in the fields of: pre and probiotics, metabolic studies, human and animal health, dental treatments and agriculture solutions (biofertilizers)
Type: CRO / CMO
Enabling Technologies
Screening
NEURAL THERAPIES CRO / CMO Screening of molecules as neuroprotectors, mainly in cerebrovascular and Alzheimer diseases. Evaluation on infarct volume, behavioral responses, inflammation, homeostatic response and cell death. Models: Focal ischemia, global ischemia, oxygen and OGD. 1R+D Screening of molecules as neuroprotectors, mainly in cerebrovascular and Alzheimer diseases. Evaluation on infarct volume, behavioral responses, inflammation, homeostatic response and cell death. Models: Focal ischemia, global ischemia, oxygen and OGD.
Type: CRO / CMO
OPERON Screening Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections 5RTM Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections
Type: Screening
PROMEGA BIOTECH IBÉRICA Enabling Technologies Maxprep Liquid Handler, robotic Nucleic Acid Purification System 5RTM Maxprep Liquid Handler, robotic Nucleic Acid Purification System
Type: Enabling Technologies
PROMEGA BIOTECH IBÉRICA Enabling Technologies
Screening
GloMax Discover Microplate Reader. Multimode Plate Reader for luminescence, fluorescence and absorbance measurements 5RTM GloMax Discover Microplate Reader. Multimode Plate Reader for luminescence, fluorescence and absorbance measurements
Type: Enabling Technologies
Screening
PROMEGA BIOTECH IBÉRICA CRO / CMO
Enabling Technologies
Custom Manufacturing. We apply our knowledge and experience in technology development, manufacturing and quality systems with a cross-functional team of peers to comply with international quality standards (ISO) and produce custom products that will be ma 5RTM Custom Manufacturing. We apply our knowledge and experience in technology development, manufacturing and quality systems with a cross-functional team of peers to comply with international quality standards (ISO) and produce custom products that will be ma
Type: CRO / CMO
Enabling Technologies
Sylentis Others SIRFINDER(TM). RNA interference prediction software based on artificial intelligence (AI) to design the best candidates for a specific target and to predict inhibition efficiency with improved specificity and sensitivity. 5RTM SIRFINDER(TM). RNA interference prediction software based on artificial intelligence (AI) to design the best candidates for a specific target and to predict inhibition efficiency with improved specificity and sensitivity.
Type: Others
VIVEBIOTECH CRO / CMO Development of more cost-effective gene therapy processes 3CV Development of more cost-effective gene therapy processes
Type: CRO / CMO
VIVEBIOTECH CRO / CMO LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile. 3CV LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile.
Type: CRO / CMO
Vivia Biotech CRO / CMO
Enabling Technologies
Screening
Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations 5RTM Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations
Type: CRO / CMO
Enabling Technologies
Screening
ZeClinics CRO / CMO
Screening
Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests, endocrine disruption assays, reproductive toxicology 5RTM Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests, endocrine disruption assays, reproductive toxicology
Type: CRO / CMO
Screening
ZeClinics CRO / CMO
Enabling Technologies
Screening
Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9. 5RTM Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9.
Type: CRO / CMO
Enabling Technologies
Screening
ZeClinics CRO / CMO
Enabling Technologies
Screening
Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings. 5RTM Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings.
Type: CRO / CMO
Enabling Technologies
Screening